Although increased aromatase and 17β-HSD1 activity in lipedema tissue has been described in some histological studies, the direct causal impact of these enzymatic patterns on disease progression remains to be fully validated in human clinical models. The gene discussed is CYP19A1; the disease is Lipedema.